Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease
Induced pluripotent stem cell (iPSC) derived dopaminergic neurons are a promising source for cell-based Parkinson’s disease (PD) therapy. Here the authors report a comprehensive pre-clinical evaluation of the safety and efficacy of dopaminergic progenitors derived from a clinical-grade human iPSC li...
Full description
Bibliographic Details
| Main Authors: |
Daisuke Doi,
Hiroaki Magotani,
Tetsuhiro Kikuchi,
Megumi Ikeda,
Satoe Hiramatsu,
Kenji Yoshida,
Naoki Amano,
Masaki Nomura,
Masafumi Umekage,
Asuka Morizane,
Jun Takahashi |
|---|
| Format: | Article
|
|---|
| Language: | English |
|---|
| Published: |
Nature Publishing Group
2020-07-01
|
|---|
| Series: | Nature Communications
|
|---|
| Online Access: | https://doi.org/10.1038/s41467-020-17165-w
|
|---|
